2-21042380-G-T
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_000384.3(APOB):c.218C>A(p.Ala73Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000545 in 1,613,548 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000384.3 missense
Scores
Clinical Significance
Conservation
Publications
- hypercholesterolemia, autosomal dominant, type BInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
- familial hypobetalipoproteinemia 1Inheritance: AR, AD, SD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
- homozygous familial hypercholesterolemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APOB | ENST00000233242.5 | c.218C>A | p.Ala73Asp | missense_variant | Exon 3 of 29 | 1 | NM_000384.3 | ENSP00000233242.1 | ||
APOB | ENST00000399256.4 | c.218C>A | p.Ala73Asp | missense_variant | Exon 3 of 17 | 1 | ENSP00000382200.4 | |||
APOB | ENST00000673739.2 | n.218C>A | non_coding_transcript_exon_variant | Exon 3 of 25 | ENSP00000501110.2 | |||||
APOB | ENST00000673882.2 | n.218C>A | non_coding_transcript_exon_variant | Exon 3 of 23 | ENSP00000501253.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152134Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000318 AC: 8AN: 251496 AF XY: 0.0000441 show subpopulations
GnomAD4 exome AF: 0.0000595 AC: 87AN: 1461414Hom.: 0 Cov.: 31 AF XY: 0.0000523 AC XY: 38AN XY: 727052 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152134Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74302 show subpopulations
ClinVar
Submissions by phenotype
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 Uncertain:2Benign:1
The c.218C>A variant identified in APOB has previously been reported in the literature in individuals with dyslipidemia [PMID:24503134, 33303402] and deposited in ClinVar as variant of unknown significance [ClinVar ID: 548044]. This variant is observed in 17 alleles (~0.003% minor allele frequency; 0 homozygote) in population databases (gnomAD v2.1.1 and v3.1.2, TOPMed Freeze 8), suggesting it is not a common benign variant in the populations represented in those databases. The c.218C>A variant is located in exon 3 of this 29-exon gene, and predicted to replace an alanine amino acid with aspartate at codon 73 (p.(Ala73Asp) within N-terminal Vitellogenin domain. In silico predictions are inconclusive of deleterious effect (CADD v1.6= 22.2, REVEL= 0.129); however, there are no functional studies to support or refute these predictions. Based on available evidence this c.218C>A p.(Ala73Asp) variant identified in APOB is classified as a Variant of Uncertain Significance. -
- -
- -
Hypercholesterolemia, familial, 1 Uncertain:1
- -
Familial hypercholesterolemia Uncertain:1
- -
not provided Benign:1
APOB: BP4 -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at